Controversy. II: Bioequivalence as an indicator of therapeutic equivalence: modeling the theoretic influence of bioinequivalence on single-dose drug effect.
Warner-Lambert/Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105.
S C
SC
Olson
M A
MA
Eldon
R D
RD
Toothaker
J J
JJ
Ferry
W A
WA
Colburn
D001682:Biological Availability; D006801:Humans; D008954:Models, Biological; D004364:Pharmaceutical Preparations / Q000008:administration & dosage; D010599:Pharmacokinetics; D013810:Therapeutic Equivalency
D004364:Pharmaceutical Preparations